MusculoskeletalICD-10: M15-M19Over 32.5 million adults in the United States; most common joint disease worldwide

Osteoarthritis

Also known as: OA, Degenerative Joint Disease, Wear-and-Tear Arthritis

Osteoarthritis is the most common form of arthritis, caused by the progressive breakdown of cartilage that cushions the ends of bones in joints. It most frequently affects the knees, hips, hands, and spine, causing pain, stiffness, and reduced mobility. While it is often associated with aging, osteoarthritis is a complex disease influenced by genetics, joint injury, obesity, and mechanical stress.

Last updated October 31, 2026

Understanding Osteoarthritis

Osteoarthritis is a disease of the whole joint, not just worn cartilage. The cartilage that caps the bone ends softens and thins, the bone beneath it thickens and grows spurs, the ligaments stiffen, the muscles around the joint weaken, and the joint lining becomes mildly inflamed. It affects over 500 million people worldwide and is the leading cause of knee and hip replacement. The old name 'wear and tear' is misleading because it suggests the joint is used up by activity; in fact joints that are regularly loaded stay healthier, and the disease is driven as much by biology, injury history and body weight as by years of use.

Cartilage has no blood supply and relies on compression during movement to pump nutrients in and waste out, which is one reason inactivity makes it worse. In osteoarthritis the chondrocytes that maintain cartilage shift into a degrading mode, releasing enzymes that break down collagen and proteoglycan faster than they are rebuilt. Fragments of cartilage irritate the synovial lining, which produces inflammatory cytokines and extra fluid, and the subchondral bone remodels and develops painful bone marrow lesions. Pain comes from the bone, lining, ligaments and tightened muscles, not from the cartilage itself, which has no nerves. This explains the weak link between X-ray severity and symptoms: many people with 'bone on bone' X-rays have modest pain, and vice versa. In long-standing cases the nervous system itself becomes sensitised, amplifying pain signals.

Osteoarthritis usually progresses slowly and unevenly; over a decade roughly a third of knees worsen noticeably on X-ray, many stay stable, and symptoms fluctuate independently. Every major guideline (ACR, OARSI, NICE) puts exercise, weight management and education first, ahead of any drug. Topical NSAID gels are the preferred medication for knee and hand disease; oral NSAIDs at the lowest dose work better but carry stomach, kidney and heart risks; paracetamol does little; duloxetine helps some people with widespread pain. Corticosteroid injections relieve pain for 2 to 6 weeks, but a 2-year trial of injections every 3 months found more cartilage loss than saline with no lasting pain benefit, so they are best used sparingly. Hyaluronic acid and PRP injections offer little or nothing over placebo, and arthroscopic 'clean-outs' are no longer recommended. Total joint replacement remains the definitive treatment for end-stage disease, with over 90 percent of implants lasting 15 years.

Natural approaches have a genuine place in osteoarthritis because the goal is symptom control over years and the comparison drugs have real risks. Curcumin has the strongest evidence, with meta-analyses of more than 15 randomised trials showing pain reductions comparable to NSAIDs over 8 to 12 weeks. Boswellia, ginger, MSM and topical capsaicin each have several positive trials. Glucosamine is the most contested: the NIH-funded GAIT trial using glucosamine hydrochloride found no benefit, while European trials of crystalline glucosamine sulfate, mostly funded by its manufacturer, found modest pain relief and slower joint-space loss, so form matters and expectations should be modest. Pharmaceutical-grade chondroitin matched celecoxib in one large trial. Collagen supplements have a few small positive trials. None of these rebuilds cartilage, and none substitutes for exercise and weight loss, which outperform every pill.

The belief that most damages people with osteoarthritis is that pain means harm and the joint should be rested. Fear of movement leads to muscle loss, weight gain and stiffness, each of which increases pain, and the downward spiral is often steeper than the disease itself. Pain during and shortly after exercise that settles within 24 hours is acceptable and expected when starting; it is not a sign of damage. People who keep walking, cycling and strength training with a sore knee consistently do better than those who protect it, and many defer or avoid surgery altogether.

At a Glance

Common symptoms
Joint pain that worsens with activity and improves with rest, Morning stiffness lasting less than 30 minutes, Reduced range of motion in affected joints
Main treatments
Regular low-impact exercise (walking, swimming, cycling), Weight management to reduce joint stress, Acetaminophen and oral or topical NSAIDs for pain
Category
Musculoskeletal · Over 32.5 million adults in the United States; most common joint disease worldwide
See a doctor if
Joint pain or stiffness that limits daily activities

Symptoms

Joint pain that worsens with activity and improves with rest
Morning stiffness lasting less than 30 minutes
Reduced range of motion in affected joints
Grating or crunching sensation (crepitus) during movement
Swelling around the joint
Bony enlargements (Heberden's and Bouchard's nodes in finger joints)
Joint instability or buckling

Causes

  • Progressive cartilage degradation from mechanical and biological factors
  • Aging and cumulative joint stress over time
  • Previous joint injury (fracture, ligament tear, meniscus injury)
  • Genetic predisposition
  • Abnormal joint mechanics or alignment

Risk Factors

  • Age over 50
  • Obesity (excess weight stresses weight-bearing joints)
  • Female sex (more common after menopause)
  • History of joint injury or surgery
  • Occupations with repetitive joint stress
  • Family history of osteoarthritis

Diagnosis

  • Clinical examination of joint tenderness, range of motion, and crepitus
  • X-rays showing joint space narrowing, osteophytes, and subchondral sclerosis
  • MRI for early detection or to assess cartilage, menisci, and ligaments
  • Blood tests mainly to rule out other types of arthritis (rheumatoid, gout)

Treatment

  • Regular low-impact exercise (walking, swimming, cycling)
  • Weight management to reduce joint stress
  • Acetaminophen and oral or topical NSAIDs for pain
  • Physical therapy to strengthen surrounding muscles
  • Intra-articular corticosteroid injections for flares
  • Joint replacement surgery (arthroplasty) for end-stage disease

Natural remedies for osteoarthritis: what the evidence says

Ranked by the strength of human evidence for osteoarthritis specifically. These sit alongside medical care, not in place of it.

  1. Meta-analyses of over 15 randomised trials in knee osteoarthritis find curcumin extracts reduce WOMAC pain and stiffness significantly more than placebo over 4 to 12 weeks, with effect sizes similar to NSAIDs. In a 367-patient trial, 1,500 mg daily of turmeric extract matched 1,200 mg ibuprofen over 4 weeks with fewer gastrointestinal complaints, and a 2021 trial of 70 patients found 2 capsules of a bioavailable extract reduced pain more than placebo over 12 weeks without changing cartilage on MRI.

    Studied dose
    500 to 1,500 mg daily of a bioavailable curcumin extract (piperine-enhanced, phospholipid or micellar) with food for at least 8 weeks.
    Cautions
    Increases bleeding tendency with warfarin, DOACs, aspirin and NSAIDs; may worsen reflux and gallstone symptoms. Rare liver injury with high-dose extracts has been reported, so check liver function if also on regular NSAIDs or statins; stop 2 weeks before joint surgery.
  2. A 2020 meta-analysis of seven randomised trials (about 545 patients) found boswellia extracts improved pain, stiffness and function versus placebo in knee osteoarthritis over 4 to 12 weeks. A 90-day trial of 75 patients found 100 mg daily of an AKBA-enriched extract cut pain scores by roughly 40 percent and lowered synovial fluid MMP-3, a cartilage-degrading enzyme. Trials are small and mostly manufacturer-funded, keeping it at Moderate.

    Studied dose
    100 to 250 mg daily of an extract standardised to boswellic acids (or 100 mg AKBA-enriched extract) with a meal containing fat.
    Cautions
    Can cause nausea, reflux and diarrhoea; may alter the metabolism of drugs handled by CYP enzymes. Avoid in pregnancy and stop before surgery because of possible antiplatelet effects.
  3. Glucosamine Sulfate

    Moderate evidence

    In the 1,583-patient NIH-funded GAIT trial, glucosamine hydrochloride 1,500 mg daily did not beat placebo overall, though a subgroup with moderate-to-severe pain improved on the glucosamine-chondroitin combination. European 3-year trials of crystalline glucosamine sulfate 1,500 mg once daily, funded by its manufacturer, found modest pain relief and about 0.3 mm less joint-space narrowing. Independent meta-analyses rate the overall pain effect as small; sulfate consistently outperforms hydrochloride.

    Studied dose
    1,500 mg crystalline glucosamine sulfate once daily; allow 3 months before judging.
    Cautions
    May slightly raise blood sugar and intraocular pressure; derived from shellfish shells, so check for allergy. Case reports of raised INR with warfarin; no safety data in pregnancy.
  4. Chondroitin Sulfate

    Moderate evidence

    In the 604-patient CONCEPT trial, pharmaceutical-grade chondroitin sulfate 800 mg daily was equivalent to celecoxib 200 mg for knee pain and function at 6 months and superior to placebo. A 2015 Cochrane review of 43 trials found a small pain benefit of about 8 points on a 100-point scale, and two 2-year trials suggested slower cartilage loss on MRI. Benefit is tied to product quality, which varies widely.

    Studied dose
    800 to 1,200 mg daily of pharmaceutical-grade chondroitin sulfate for at least 3 months.
    Cautions
    Chemically related to heparin and may add to bleeding risk with anticoagulants; mild stomach upset is common. Many over-the-counter products contain less chondroitin than labelled, so choose a brand with independent testing.
  5. Capsaicin Cream (Topical)

    Moderate evidence

    Capsaicin cream depletes substance P from pain nerve endings; pooled trials in hand and knee osteoarthritis found 0.025 to 0.075 percent cream applied four times daily for 4 to 12 weeks reduced pain by roughly 30 to 50 percent more than placebo cream, and the 2019 ACR guideline conditionally recommends it for knee disease. Initial burning for the first 1 to 2 weeks causes many people to stop early, which limits the trials.

    Studied dose
    0.025 to 0.075 percent capsaicin cream applied thinly to the painful joint 3 to 4 times daily for at least 4 weeks.
    Cautions
    Burns and stings on application for the first 1 to 2 weeks; wash hands thoroughly afterwards and keep away from eyes, mucous membranes and broken skin. Avoid applying under heat pads or before bathing, and do not combine with other topical NSAIDs on the same area without advice.
  6. Ginger

    Moderate evidence

    A 2015 meta-analysis of five randomised trials (593 patients) found ginger extract modestly reduced osteoarthritis pain and disability versus placebo. The largest, a 6-week trial of 261 knee patients, found 255 mg of concentrated extract twice daily improved pain on standing in 63 percent versus 50 percent on placebo, with more stomach upset. Topical ginger compresses have one small positive trial. The effect is smaller than curcumin or boswellia.

    Studied dose
    250 mg standardised extract two to three times daily, or 1 to 1.5 g dried ginger powder daily, with food.
    Cautions
    Mild antiplatelet effect adds to bleeding risk with warfarin, DOACs and NSAIDs; frequently causes heartburn. Large doses may lower blood sugar and blood pressure.
  7. Undenatured type II collagen at 40 mg daily outperformed placebo and glucosamine-chondroitin for knee pain and WOMAC scores in a 191-patient, 180-day trial, acting through oral immune tolerance rather than as a building block. Hydrolysed collagen at 10 g daily improved pain in a few small trials totalling several hundred patients, and a 2019 meta-analysis found a significant reduction in WOMAC stiffness but not total pain. Trials are few and mostly industry-funded.

    Studied dose
    40 mg undenatured type II collagen once daily, or 10 g hydrolysed collagen peptides daily, for at least 3 to 6 months.
    Cautions
    Generally well tolerated; mild nausea and fullness are the main complaints. Products are animal-derived (chicken sternum or bovine/marine), so check allergies; calcium content in some marine products matters for people with hypercalcaemia or kidney stones.
  8. Three randomised trials in knee osteoarthritis, about 170 patients in total, found 3 to 6 g of MSM daily for 12 weeks modestly improved pain and function; a 50-patient trial of 3 g twice daily cut WOMAC pain by about 14 points on a 100-point scale compared with 5 on placebo. A combination with glucosamine performed better than either alone in one Indian trial. The evidence base remains small.

    Studied dose
    1.5 to 3 g twice daily (3 to 6 g per day) with food for 12 weeks.
    Cautions
    Usually well tolerated; may cause bloating, loose stools and insomnia if taken in the evening. No significant drug interactions are known, but data beyond 6 months of use are lacking.

What matters day to day

  • Exercise is the first-line treatment, not an add-on: across more than 50 trials, land-based exercise reduces knee osteoarthritis pain by about 12 points on a 100-point scale, similar to oral NSAIDs, and the benefit lasts for months after a programme ends.
  • Lose weight if you are carrying extra: in the 18-month IDEA trial, losing 10 percent of body weight halved knee pain and cut knee-joint compressive forces by about 400 newtons per step; diet plus exercise beat either alone.
  • Strengthen your quadriceps and hips: weaker thigh muscles predict faster knee osteoarthritis progression, and 2 to 3 sessions a week of resistance work reduces pain by about 30 percent in trials.
  • Keep walking: a 2022 analysis of over 1,200 people with knee osteoarthritis found regular walking for exercise was associated with 40 percent lower odds of developing frequent knee pain and less structural worsening on X-ray.
  • Accept some soreness: pain during exercise that settles within 24 hours and does not worsen week on week is safe and expected; monitoring with this '24-hour rule' keeps people active without flaring the joint.

Prevention

  • Maintain a healthy weight throughout life
  • Stay physically active with joint-friendly exercises
  • Protect joints from injury during sports and physical activities
  • Strengthen muscles around vulnerable joints

When to See a Doctor

  • Joint pain or stiffness that limits daily activities
  • Joint swelling, redness, or warmth
  • Joint symptoms that do not improve with over-the-counter treatments
  • Joint deformity or instability

Frequently Asked Questions

References

  1. Kolasinski SL, Neogi T, Hochberg MC, et al.. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care and Research (2020)
  2. Messier SP, Mihalko SL, Legault C, et al.. Effects of Intensive Diet and Exercise on Knee Joint Loads, Inflammation, and Clinical Outcomes Among Overweight and Obese Adults With Knee Osteoarthritis (IDEA). JAMA (2013)
  3. McAlindon TE, LaValley MP, Harvey WF, et al.. Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis. JAMA (2017)
  4. Clegg DO, Reda DJ, Harris CL, et al.. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis (GAIT). New England Journal of Medicine (2006)
  5. Reginster JY, Dudler J, Blicharski T, Pavelka K. Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes and symptoms (CONCEPT). Annals of the Rheumatic Diseases (2017)
  6. Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, et al.. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clinical Interventions in Aging (2014)
  7. Bennell KL, Paterson KL, Metcalf BR, et al.. Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis (RESTORE). JAMA (2021)
  8. Fransen M, McConnell S, Harmer AR, et al.. Exercise for osteoarthritis of the knee. Cochrane Database of Systematic Reviews (2015)
  9. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Osteoarthritis (2023)View source

Related Conditions

Lab tests that relate to osteoarthritis

Related from the Supplement Library

These supplements have been studied in relation to Osteoarthritis. Always consult your healthcare provider before starting any supplement, especially if you take medications.

Have questions about Osteoarthritis?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.